chrisvoncsefalvay/vaers-outcomes huggingface dataset:
No adverse effects were reported; Patients were administered improperly stored vaccines doses; This spontaneous report was received from a registered nurse, concerning a patient of unspecified age and gender. The patient's pertinent medical history, concurrent conditions, drug reactions, allergies and concomitant medications were not reported.   On 23-APR-2019, the patient was vaccinated with improperly storage doses of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) for prophylaxis, lot #R034700 and expiration date 16-JUN-2020 (strength, dose, frequency and route of administration were not reported); with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) for prophylaxis, lot #R033080 and expiration date 06-JUN-2020 (strength, dose, frequency and route of administration were not reported); and with hepatitis a vaccine, inactivated (VAQTA) for prophylaxis lot #S001485, expiration date 12-MAY-2020 and lot #R012988 and expiration date 30-MAY-2019. No adverse effects were reported.   The temperature excursion was reported as below 36°F (35.4°F) during a time frame of 27 minutes. Previous temperature excursion was reported as below 36°F (35.4°F) during a time frame of 15 minutes.   A digital data logger was involved.    This is one of several reports received from the same  reporter.; Sender's Comments:  US-009507513-1904USA012221: US-009507513-1905USA002744: US-009507513-1905USA002745: US-009507513-1905USA002746: US-009507513-1905USA002747: US-009507513-1905USA002748: US-009507513-1905USA002749: US-009507513-1905USA002750: US-009507513-1905USA002751: US-009507513-1905USA002752: US-009507513-1905USA002753: US-009507513-1905USA002754: US-009507513-1905USA002755: US-009507513-1905USA002756: US-009507513-1905USA002757: US-009507513-1905USA002758: US-009507513-1905USA002759: US-009507513-1905USA002760: US-009507513-1905USA002761: US-009507513-1905USA002762: US-009507513-1905USA002763: US-009507513-1905USA002764: US-009507513-1905USA002765: US-009507513-1905USA002766: US-009507513-1905USA002767: US-009507513-1905USA002768: US-009507513-1905USA002770:
full body rash in the form of red itchy bumps. more prominent on thighs, hips and ankles.
So I had a long discussion with this patient about her experience after receiving the SHINGRIX vaccine on 2/20/18. She stated that right after she received the shot her arm hurt for a few days and she had a hard time lifting her arm (for Zumba). She figured this was a typical reaction to a vaccine so did not worry about it. The shoulder pain persisted so she ended up doing PT and using a variety of topicals to treat the pain. After months and months of no change or improvement, she saw an MD who did an MRI to confirm that she had bursitis with a tear in her bursa. The MD told her it was the result of improper vaccine administration (too high and too deep she stated). She is due to have surgery to repair the tear on 4/22/19 and is expected to have 6 months of PT as follow up.
"Acute onset of illness at about 0130 with crying and fussiness, poorly consolable and vomited a short time later. Patient seemed to have abdominal pain. Ultrasound obtained which demonstrated INTUSSUSCEPTION. Total of 2 episodes of vomiting. No stools. No fever or other signs or symptoms of illness. Patient was his usual self yesterday. Otherwise generally healthy." "Ultrasound here demonstrates persistence of the INTUSSUSCEPTION - reduced successfully by contrast enema. Able to take and retain po fluids without problems. Will discharge with care instructions."
Date of Admission: 10/21/2021   Date of Discharge: 10/24/2021 Hospital Course and Significant Findings: 68 year old man with history of HCV s/p tx, hep C cirrhosis, hypertension, s/p JJ vaccine 4/21, recent travel, exposure to sick family members who presents with weakness due to covid disease.  Tested + 10/11. Seen in ED 10/19, dc'd home, returns on 10/21 with worsening weakness, hypernatremia, acidosis. Weakness likely due to covid disease and hypernatremia, acidosis due to dehydration/volume depletion. Improved with hydration. Pt tolerating 100% diet and worked with PT, recommend HHPT. Pt remains stable on room air, not hypoxic. discharged home with nieces.   Reason for Hospital Admission (Admitting Diagnosis):  Weakness and hypernatremia due to covid
Patient that came to get their second dose, received a half a dose instead of a full dose for their second vaccine series; This spontaneous case was reported by a physician assistant and describes the occurrence of ACCIDENTAL UNDERDOSE (Patient that came to get their second dose, received a half a dose instead of a full dose for their second vaccine series) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 ml. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (Patient that came to get their second dose, received a half a dose instead of a full dose for their second vaccine series). At the time of the report, ACCIDENTAL UNDERDOSE (Patient that came to get their second dose, received a half a dose instead of a full dose for their second vaccine series) had resolved.            No concomitant product use was provided by the reporter. No treatment medication was provided. No medical history was reported.
One hour following vaccine administration, parent reports weakness, dizziness and staggering.  Symptoms subsided following 8 hours of bedrest at home.  Parent did not report incident immediately to provider.  Parent brought patient in on 3/31/03 to report incident.
allergy in the arm; it got very very hot; itchy; my arm swelled; it got really read; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (allergy in the arm), VACCINATION SITE WARMTH (it got very very hot), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE SWELLING (my arm swelled) and VACCINATION SITE ERYTHEMA (it got really read) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced VACCINATION SITE REACTION (allergy in the arm), VACCINATION SITE WARMTH (it got very very hot), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE SWELLING (my arm swelled) and VACCINATION SITE ERYTHEMA (it got really read). At the time of the report, VACCINATION SITE REACTION (allergy in the arm), VACCINATION SITE WARMTH (it got very very hot), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE SWELLING (my arm swelled) and VACCINATION SITE ERYTHEMA (it got really read) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was provided. No treatment medication information was provided    Reporter did not allow further contact
nose bleeds (epistatis)  140/90 BP P-80  o2 98%  #21 went home
severe cold chills started at 3am no fever used heating pad to get warm then had to work the next day severe aches and chills again with some nausea  took ibuprofen at 9am and chills and aches went away for about 5.5 hours then returned but not as severe.  right arm pain x 2 days
This spontaneous report as received from a nurse practitioner refers to a female patient of unknown age. In May, 2011 the patient was vaccinated with her first dose of GARDASIL (lot # not reported). On 03-OCT-2012 the patient was vaccinated with her second dose of GARDASIL (lot # not reported). No adverse symptoms reported. It was unknown if the patient sought medical attention. Additional information has been requested.
On 7/19/09 noted lethargy, headache when moves around too much.  No elevated temperature, no vomiting.  Encouraged to give Tylenol or Ibuprophen for pain, to see physician for symptoms.
Within 2 hrs---Blinding headache, confusion. At 12 hrs---Blinding headache, extreme confusion, fatigue. At 24 hrs---chills, Blinding headache, extreme confusion, fatigue, bone aches-wrist and ankle. Left work early because of symptoms, unable to perform any activities other than complete bedrest. Blinding headache not relieved by 800mg ibu. Difficultly falling asleep. Woke up in 4 hrs when 800mg ibu wore off and need another dose. At 36 hrs---headache present (but improved from previous), extreme fatigue. Experienced similar with first dose (7/2018) but onset of symptoms was swifter with 2nd dose.  1st dose fatigue did not resolve for 21 days.
site administration tenderness; This is a spontaneous report from a contactable pharmacist. An adult male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration on 12Mar2021 (Batch/Lot number was not reported) as 2nd dose, single dose for COVID-19 immunisation. The vaccination facility type was at the workplace clinic. The patient's medical history and concomitant medications were not reported. It was unknown if other vaccine was administered in four weeks. The patient previously received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. On 12Mar2021, the patient experienced site administration tenderness after receiving second COVID-19 dose. The event did not result in any visit to Emergency Room or Physician office. It was unknown if treatment was given. The outcome of the event was unknown.  Information about lot/batch number cannot be obtained. No further information expected.
Loss of hair; This is a spontaneous report from a contactable 51-year-old male patient reported for himself that:  A 51-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EK4176) via an unspecified route of administration, administered in Arm Right on 07Jan2021 as DOSE 2, SINGLE for covid-19 immunisation. Medical history included alopecia, known allergies: pollen. The patient's concomitant medications were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EH9899) via an unspecified route of administration, administered in Arm Left on 17Dec2021 02:00 as DOSE 1, SINGLE for covid-19 immunisation. Patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Patient had not received any other medications the patient received within 2 weeks of vaccination. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On, 11an2021, the patient experienced loss of hair. The clinical outcome of event was recovering.  Follow-up attempts are completed. No further information is expected.; Sender's Comments: s
First day post vaccination, began with symptoms of upper respiratory illness including oral pharyngeal, nasal pharyngeal, and sinus related congestion with persistent shortness of breath which has persisted since
Stomach pain severe for weeks in February, still suffer  Abnormal muscle pain during and after exercise, muscles not recovering normal still happpening reduced stamina still haven't recovered shortness of breath still happening vivid dreams left me feeling awake all night for approx 1 month Feb-March, still happening occasionally
I was positive for COVID-19 on 23FEB2023, I was congested and I had a lot of mucus. I started coughing heavily, I thought it was a cold I tested it was negative than I thought it was over, than I came back and tested again and it was positive. I contacted my doctor, he prescribed me PAXLOVID and I started feeling better about 2 days later but fully better after 5 days. I still have a lingering cough that won't go away.
Here to receive 2nd dose Moderna, when needle withdrawn from arm the vaccine "exploded" from the injection site and a large amount ran down the arm.  After consultation with NP and MD, the patient was revaccinated with a new dose of Moderna.
missed his second dose; Chest Pain; Increased Heart rate; Palpitation; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CHEST PAIN (Chest Pain), HEART RATE INCREASED (Increased Heart rate), PALPITATIONS (Palpitation) and PRODUCT DOSE OMISSION ISSUE (missed his second dose) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Heart disease, unspecified.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jan-2021, the patient experienced CHEST PAIN (Chest Pain), HEART RATE INCREASED (Increased Heart rate) and PALPITATIONS (Palpitation). On 15-Feb-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (missed his second dose). On 15-Feb-2021, PRODUCT DOSE OMISSION ISSUE (missed his second dose) had resolved. At the time of the report, CHEST PAIN (Chest Pain), HEART RATE INCREASED (Increased Heart rate) and PALPITATIONS (Palpitation) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Jan-2021, Heart rate: increased (High) increased.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Subject in pneumococcal vaccine trial, with severe COPD, was hospitalized with a superficial sternal wound infection. Vaccination took place on 3/19/2009. According to the physician, the relationship is none. We would be happy to fax you the studys SAE report.
Severe vertigo (diagnosed) that started 4 days after 1st dose and persists to current date.
Per patient pain started immediately but they thought it was part of the shot. Pain was intense per patient. Pain lasted for weeks and now has left a click and trouble raising arm high with shoulder
Pregnant currently 8 weeks, baby doing fine at this moment.   About 10 hours or so after my 2nd vaccine, I started getting chills, low grade fever of 99.5F and it gradually got worse in the middle of the night, fever had spiked to 101.6F. I have history of pregnancy loss. I took some Tylenol for the fever and by the next morning my fever was better and my fever resolved.   I got the swelling and erythema at the injection site, was bot four inches long and 3 inches wide and it was also itchy.  The fever and chills resolved by the evening of hte next day.  The swelling and erythema went down in a few days.
Severe Nausea, Swollen lymph nodes, cold sweats, sore throat,
severe headaches, extremely sensitive skin (slight touch caused high pain- all over body), fever over 100° for over 12 hours from start, joint pain, fatigue
Patient describes diarrhea, sinus headache, congestions which turns into a headache. Patient also report odd cramping in legs, especially in the rear thigh muscles. Slight nausea but cause unknown.
Hives + fever on arms and legs 1/21, woke up 1/22 with very bad rash on right lower leg. Seen by PCP 1/22 treated with BENADRYL for rash and TYLENOL for fever.
had waves of spasms that would start at my stomach and go up ward about every two to three minutes..  no dizziness, not nauseous stayed at valley medical for about two hours..  took  two 25 mg of benadryl at two different intervals.  as blood pressure and heat rate came down left.    took 50mg for the rest of the day 1 ad day two every 4-6 hrs  and dropped to 25mg for a day and a half.   Have an appointment with allergist before the second vaccine.
vaccine given 6 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine given 6 days post expiry) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C21A and 011J20A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine given 6 days post expiry). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (vaccine given 6 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication information was reported. No Treatment medications were provided  Patient had Adverse event none,  the  vaccine given 6 days post expiry.   This case was linked to MOD-2021-395985 (Patient Link).
Swelling of Parotid glands, bilateral and recurrent additional symptoms fatigue, dry mouth, dry eyes Treated with a course of Medrol Pack and changed Flonase to Azelastine HCl 0.1% Positive response with swelling and symptoms relieved Parotid swelling reoccurred, seen for second visit on 6/15/2021. Referred to ENT Treated with Prednisone 30 mg daily x 7 days and course of Augmentin -  swelling decreased
Major Hives throughout entire body including scalp area its been 3 weeks that I've suffered and had to call a prescription in for oral steroids
This case was reported by a consumer via call center representative and described the occurrence of injection site muscle pain in a 87-year-old male patient who received Shingrix for prophylaxis. Concomitant products included Shingrix. On 12th August 2018, the patient received the 2nd dose of Shingrix. On 13th August 2018, 1 days after receiving Shingrix, the patient experienced fatigue. In August 2018, the patient experienced injection site muscle pain and injection site erythema. On an unknown date, the outcome of the injection site muscle pain and fatigue were recovered/resolved and the outcome of the injection site erythema was recovering/resolving. It was unknown if the reporter considered the injection site muscle pain, fatigue and injection site erythema to be related to Shingrix. Additional details were provided as follows: This case was reported by the patient's wife. In early June 2018, the patient received 1st dose of Shingrix (for tolerance to 1st dose refer linked case US2018GSK153538). Less than a week after receiving 2nd dose of Shingrix, the patient experienced muscle pain close to the injection site with both injections and redness close to the injection site with his second dose. The redness close to the injection site was almost gone. The patient also felt wiped out with fatigue the following day after receiving both shots. This case has been linked with US2018149464, reported by the same reporter.
Patient seen in the emergency department on 5/30 for generalized weakness, rigors, fever, cough, and malaise. She has medical history of CKD. Patient admitted to the hospital from 5/30-6/4. This meets criteria for VAERS reporting.
I had the seasonal Influenza vaccine injected into my L deltoid during work hours on 10/30/19.  I had my menstrual cycle at this time which I informed the nurse of. My menstrual cycles occurred monthly for 5-7 days.  On 11/12/21 I had spotting which was intermittent lasting several days. Toward the end of month this reoccured and bleeding became heavier presenting as my typical monthly menscis. The blood flow continued past my usual 5-7 day time frame.  The heavy vaginal bleeding continued without interruption worsening throughout the month of december and into January until I was changing a tampon and a heavy flow pad every 1-2 hours.  When I realized this irregularity was not going to improve I went to see Dr,
Redness, warmth, hardness, and pain at site of injection. Patient having difficulty lifting arm above shoulder height when palm facing upward. Symptoms have very slowly improved but still present 5 days later.
Developed headache, abdominal pain, and low grade fever on 10/6/21. He has had no nausea/ vomiting/ diarrhea. Of note, he also received the Gardasil vaccine (dose #1) concurrently with his Pfizer COVID-19 vaccine. HPV vaccine was received in right arm, lot # T026324.
This spontaneous case reported by a consumer, describes the occurrence of chest discomfort (chest tightness), dyspnea (could not breath) and swelling in the chest in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 030A21A) for COVID-19 immunization. No medical history reported. On Mar 9, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19  vaccine), intramuscular; 1 dosage form. On Mar 24, 2021, patient experienced chest discomfort (chest tightness), dyspnea (could not breath) and swelling in the chest. At the time of the report, chest discomfort (chest tightness), dyspnea (could not breath) and swelling in the chest outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medication use provided by the reporter. No treatment of events reported. Most recent follow-up information incorporated above included: On Apr 7, 2021: Voicemail left for patient to call back. Reporter's comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Severe dizziness and slight headache that started at 9:00 PM on 11/18/2010.
Patient given Pediarix instead of separate vaccines - DTaP, IPV, HBV
Information has been received from a physician concerning a female (age not reported) with rheumatoid arthritis who on an unspecified date was vaccinated with HPV rL1 6 11 16 18 VLP vaccine (yeast). Subsequently, the patient developed dizziness, stiffness in joints and abdominal cramping. The patient sought unspecified medical attention. At the time of this report, the patient had recovered from the events (date unknown). Additional information has been requested.
About 4 1/2 weeks after the  2nd dose I on( 6/22/21 ) woke up and felt DIZZINESS. It's only positional when the head is turned to the right side or laying down. I don't know if this is related to the Vaccine but I never had this before so I'm reporting it here just in case you guys can see a pattern here. I'm still experiencing the problem one week after it started, not getting worse but neither getting away. At times it seems that it's getting better but comes back again same intensity.
C/O ITCHINESS, NO REDNESS NOTED, 50 MG BENADRYL GIVEN. 154/92, 93, REDNESS TO NECK APPEARING AT 0924.  0938 NO NEW S/S, NECK REDNESS REDUCING.
Reported not feeling well at midnight 11/9/02 before going to bed; reports achiness, headaches, and nasal congestion, which began earlier in the evening. Awoke at 05:00 with itching and hives. The hives were present to bilateral arms, bilateral thighs, lower abdomen and left flank area. No respiratory distress noted. Treated with IM Benadryl 50mg x1 to left gluteus. Then continued with PO Benadryl for 2 days per package directions. A decrease in redness and itching was not after IM Benadryl administration.
EXCESSIVE BRUISING (BLACKENING) OF THE RIGHT OUTTER EDGE EYE LID.
Pt devel rash over entire arm, down to the elbow p/receiving Td; Area was hot & swollen; pt had fever several days;